bortezomib,lenalidomide,dexamethasone,daratumumab
janssen,takeda
day 3 #ims2022 plenary abstract session nct02874742 : phase 2 - daratumumab, len., bortezomib &amp; dex (d-rvd) vs (rvd) in new mm - griffin #mmsm #multiplemyeloma #curemyeloma 
Multiple Myeloma Education Platform for Myeloma Community